This session with Dr Michelle Hermiston (UCSF) will focus on identifying HLH as a clinical syndrome that can be caused by multiple etiologies; explain the pathophysiology of HLH and its common manifestations; describe treatment modalities for newly diagnosed and refractory patients.

We are pleased to share with you in VIVA's 2019 Annual Report, which highlights the breadth of our work—from childhood cancer research to knowledge exchanges with medical professionals in the region, to fun days out in support of patients and survivors, to fundraising events organised by our very generous donors.

In September, on Childhood Cancer Awareness Month, support VIVA's work as we continue to fund leading-edge research towards better cures, share knowledge with medical practitioners to improve the level of medical care for kids with cancer across Singapore and beyond; and develop a holistic programme of care for survivors and patients beyond treatment. 

In this editorial on Cancer Research, Statistics and Treatment, VIVA alumni Dr Shweta Bansal,Dr Mae Dolendo, Dr Thi Kim Hoa Nguyen, and Dr Krishna Sharma provide guidelines on how to manage childhood cancer patients during the #COVID19 crisis, and how the pandemic has posed different challenges across low- and middle-income countries.